David P. Rooker

(3<i>R</i>)-<i>N</i>-(1-(<i>tert</i>-Butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1<i>H</i>- 1,4-benzodiazepin-3-yl)-<i>N</i>‘-(3-(methylamino)phenyl)urea (YF476):  A Potent and Orally Active Gastrin/CCK-B Antagonist

Graeme Semple, Hamish Ryder, David P. Rooker et al. · Journal of Medicinal Chemistry · 1997 · 73 citations · Full text

Rat Pancreas, Gastrointestinal Pharmacology, Gastroenterology +17

New Benzylureas as a Novel Series of Potent, Nonpeptidic Vasopressin V2 Receptor Agonists

Christopher Yea, Christine E. Allan, Doreen M. Ashworth et al. · Journal of Medicinal Chemistry · 2008 · 37 citations · Full text

Benzyl Group, Pharmacotherapy, Molecular Pharmacology +19

Peptidomimetic aminomethylene ketone inhibitors of interleukin-1β-converting enzyme (ICE)

Graeme Semple, Doreen M. Ashworth, Andrzej R. Batt et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 30 citations · Full text

Inflammation, Molecular Pharmacology, Medicinal Chemistry +8

PYRIDONE-BASED PEPTIDOMIMETIC INHIBITORS OF INTERLEUKIN-1β-CONVERTING ENZYME (ICE)

Graeme Semple, Doreen M. Ashworth, Graham R. Baker et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 30 citations

Inflammation, Molecular Pharmacology, Medicinal Chemistry +7

Novel cholecystokinin receptor ligands: Oxopiperazines derived from Boc-CCK-4

Andrzej R. Batt, David A. Kendrick, Elizabeth A. Mathews et al. · Bioorganic & Medicinal Chemistry Letters · 1994 · 15 citations

Molecular Pharmacology, Biochemistry, Medicine +6